Long-Term Outcomes of Patients with Epstein-barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ Transplant or Allogeneic Hematopoietic Cell Transplant Treated with Tabelecleucel in an Expanded Access Program Study

請用此 Handle URI 來引用此文件： http://scholars.ntou.edu.tw/handle/123456789/1331

標題:	Long-Term Outcomes of Patients with Epstein-barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ Transplant or Allogeneic Hematopoietic Cell Transplant Treated with Tabelecleucel in an Expanded Access Program Study
作者:	Prockop, S. Reshaf, R. Tsai, D. Bunin, N. Abu-Arja, R. Mahadeo, K. Weng, W. Van Besien, K. Loeb, D. Nasta, S. D. Nemecek, E. Hiremath, M. Yue, S. Sun, Y. Navarro, W. Nikiforow, S.
公開日期:	四月-2020
卷:	20
來源出版物:	American Journal of Transplantation
URI:	http://scholars.ntou.edu.tw/handle/123456789/1331
ISSN:	1600-6135
顯示於：	河海工程學系

顯示文件完整紀錄

上周
0

上個月
0

checked on 2022/10/13

檢查

TAIR相關文章